Table 6.
Consider BMD testing in the following individuals: |
• Women age 65 and older and men age 70 and older, regardless of clinical risk factors |
• Younger postmenopausal women, women in the menopausal transition, and men age 50 to 69 with clinical risk factors for fracture |
• Adults who have a fracture at or after age 50 |
• Adults with a condition (e.g., rheumatoid arthritis) or taking a medication (e.g., glucocorticoids in a daily dose ≥5 mg prednisone or equivalent for ≥3 months) associated with low bone mass or bone loss |